These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 17828749)

  • 21. Surfactant-mediated dissolution: contributions of solubility enhancement and relatively low micelle diffusivity.
    Balakrishnan A; Rege BD; Amidon GL; Polli JE
    J Pharm Sci; 2004 Aug; 93(8):2064-75. PubMed ID: 15236455
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dissolution properties of co-amorphous drug-amino acid formulations in buffer and biorelevant media.
    Heikkinen AT; DeClerck L; Löbmann K; Grohganz H; Rades T; Laitinen R
    Pharmazie; 2015 Jul; 70(7):452-7. PubMed ID: 26373205
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fraction of a dose absorbed estimation for structurally diverse low solubility compounds.
    Sugano K
    Int J Pharm; 2011 Feb; 405(1-2):79-89. PubMed ID: 21134428
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A theoretical-empirical analysis on the initial dissolution rate of drugs from polydispersed particles.
    Takano R; Takata N; Shiraki K; Higo S; Hayashi Y; Yamashita S
    Biol Pharm Bull; 2009 Nov; 32(11):1885-91. PubMed ID: 19881303
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of sodium dodecyl sulphate on the dissolution of poorly soluble drug into biorelevant medium from drug-surfactant discs.
    Madelung P; Ostergaard J; Bertelsen P; Jørgensen EV; Jacobsen J; Müllertz A
    Int J Pharm; 2014 Jun; 467(1-2):1-8. PubMed ID: 24594297
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Miniaturization of powder dissolution measurement and estimation of particle size.
    Avdeef A; Tsinman K; Tsinman O; Sun N; Voloboy D
    Chem Biodivers; 2009 Nov; 6(11):1796-811. PubMed ID: 19937817
    [TBL] [Abstract][Full Text] [Related]  

  • 27. General solution for diffusion-controlled dissolution of spherical particles. 1. Theory.
    Wang J; Flanagan DR
    J Pharm Sci; 1999 Jul; 88(7):731-8. PubMed ID: 10393573
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analytical methods for dissolution testing of nanosized drugs.
    Jünemann D; Dressman J
    J Pharm Pharmacol; 2012 Jul; 64(7):931-43. PubMed ID: 22686341
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Disintegration rate and properties of active pharmaceutical ingredient particles as determined from the dissolution time profile of a pharmaceutical formulation: an inverse problem.
    Horkovics-Kovats S
    J Pharm Sci; 2014 Feb; 103(2):456-64. PubMed ID: 24338791
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modeling dissolution of sparingly soluble multisized powders.
    de Almeida LP; Simöes S; Brito P; Portugal A; Figueiredo M
    J Pharm Sci; 1997 Jun; 86(6):726-32. PubMed ID: 9188056
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dissolution and coarsening of polydisperse, polymorph drug particles liberated from a disintegrating finished dosage form: Theoretical considerations.
    Horkovics-Kovats S
    Eur J Pharm Sci; 2016 Aug; 91():265-77. PubMed ID: 27155254
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of Biorelevant Media Components on Dissolution Behaviour of 1,2,4-Thiadiazole Derivative Designed for Alzheimer's Disease Prevention.
    Promzeleva M; Chislov M; Volkova T; Proshin A; Kumeev R; Terekhova I
    Chem Biodivers; 2018 Feb; 15(2):. PubMed ID: 29427367
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug release from matrix tablets: physiological parameters and the effect of food.
    Nokhodchi A; Asare-Addo K
    Expert Opin Drug Deliv; 2014 Sep; 11(9):1401-18. PubMed ID: 24970101
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of a standardized dissolution test method for inhaled pharmaceutical formulations.
    Son YJ; McConville JT
    Int J Pharm; 2009 Dec; 382(1-2):15-22. PubMed ID: 19665533
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A mechanistic study of danazol dissolution in ionic surfactant solutions.
    Sun W; Larive CK; Southard MZ
    J Pharm Sci; 2003 Feb; 92(2):424-35. PubMed ID: 12532392
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mathematical modeling of drug dissolution.
    Siepmann J; Siepmann F
    Int J Pharm; 2013 Aug; 453(1):12-24. PubMed ID: 23618956
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biorelevant Drug Solubility Enhancement Modeled by a Linear Solvation Energy Relationship.
    Niederquell A; Kuentz M
    J Pharm Sci; 2018 Jan; 107(1):503-506. PubMed ID: 28864357
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of the enhanced oral bioavailability of fenofibrate lipid formulations in fasted humans using an in vitro-in silico-in vivo approach.
    Fei Y; Kostewicz ES; Sheu MT; Dressman JB
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1274-84. PubMed ID: 23500116
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Importance of particle size decrease in the preformulation].
    Szunyogh T; Ambrus R; Szabóné RP
    Acta Pharm Hung; 2011; 81(1):29-36. PubMed ID: 21595303
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Theoretical Analysis of Drug Dissolution: I. Solubility and Intrinsic Dissolution Rate.
    Shekunov B; Montgomery ER
    J Pharm Sci; 2016 Sep; 105(9):2685-2697. PubMed ID: 26906172
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.